258 related articles for article (PubMed ID: 21381154)
1. Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.
Samson CM; Jurickova I; Molden E; Schreiner W; Colliver J; Bonkowski E; Han X; Trapnell BC; Denson LA
Inflamm Bowel Dis; 2011 Dec; 17(12):2443-55. PubMed ID: 21381154
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.
Han X; Uchida K; Jurickova I; Koch D; Willson T; Samson C; Bonkowski E; Trauernicht A; Kim MO; Tomer G; Dubinsky M; Plevy S; Kugathsan S; Trapnell BC; Denson LA
Gastroenterology; 2009 Apr; 136(4):1261-71, e1-3. PubMed ID: 19230854
[TBL] [Abstract][Full Text] [Related]
3. Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis.
D'Mello S; Trauernicht A; Ryan A; Bonkowski E; Willson T; Trapnell BC; Frank SJ; Kugasathan S; Denson LA
Inflamm Bowel Dis; 2012 Feb; 18(2):236-45. PubMed ID: 21337672
[TBL] [Abstract][Full Text] [Related]
4. Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury.
Han X; Gilbert S; Groschwitz K; Hogan S; Jurickova I; Trapnell B; Samson C; Gully J
Gut; 2010 Aug; 59(8):1066-78. PubMed ID: 20584783
[TBL] [Abstract][Full Text] [Related]
5. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
[TBL] [Abstract][Full Text] [Related]
6. Impaired CCR9/CCL25 signalling induced by inefficient dendritic cells contributes to intestinal immune imbalance in nonalcoholic steatohepatitis.
Gao W; Wang Y; Bi J; Chen X; Li N; Wang Y; Tang H; Mao J
Biochem Biophys Res Commun; 2021 Jan; 534():34-40. PubMed ID: 33310185
[TBL] [Abstract][Full Text] [Related]
7. The chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice.
Wermers JD; McNamee EN; Wurbel MA; Jedlicka P; Rivera-Nieves J
Gastroenterology; 2011 May; 140(5):1526-35.e3. PubMed ID: 21300065
[TBL] [Abstract][Full Text] [Related]
8. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
[TBL] [Abstract][Full Text] [Related]
10. Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis.
Rivera-Nieves J; Ho J; Bamias G; Ivashkina N; Ley K; Oppermann M; Cominelli F
Gastroenterology; 2006 Nov; 131(5):1518-29. PubMed ID: 17101325
[TBL] [Abstract][Full Text] [Related]
11. CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis.
Wurbel MA; McIntire MG; Dwyer P; Fiebiger E
PLoS One; 2011 Jan; 6(1):e16442. PubMed ID: 21283540
[TBL] [Abstract][Full Text] [Related]
12. Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn's disease.
Gathungu G; Zhang Y; Tian X; Bonkowski E; Rowehl L; Krumsiek J; Nix B; Chalk C; Trapnell B; Zhu W; Newberry R; Denson L; Li E
World J Gastroenterol; 2018 Feb; 24(5):623-630. PubMed ID: 29434451
[TBL] [Abstract][Full Text] [Related]
13. Imprinting of CCR9 on CD4 T cells requires IL-4 signaling on mesenteric lymph node dendritic cells.
Elgueta R; Sepulveda FE; Vilches F; Vargas L; Mora JR; Bono MR; Rosemblatt M
J Immunol; 2008 May; 180(10):6501-7. PubMed ID: 18453568
[TBL] [Abstract][Full Text] [Related]
14. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
[TBL] [Abstract][Full Text] [Related]
15. NOD2 modulates immune tolerance via the GM-CSF-dependent generation of CD103
Prescott D; Maisonneuve C; Yadav J; Rubino SJ; Girardin SE; Philpott DJ
Proc Natl Acad Sci U S A; 2020 May; 117(20):10946-10957. PubMed ID: 32350141
[TBL] [Abstract][Full Text] [Related]
16. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
[TBL] [Abstract][Full Text] [Related]
17. Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn's disease.
Saruta M; Yu QT; Avanesyan A; Fleshner PR; Targan SR; Papadakis KA
J Immunol; 2007 Mar; 178(5):3293-300. PubMed ID: 17312180
[TBL] [Abstract][Full Text] [Related]
18. Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity.
Jurickova I; Collins MH; Chalk C; Seese A; Bezold R; Lake K; von Allmen D; Frischer JS; Falcone RA; Trapnell BC; Denson LA
Clin Exp Immunol; 2013 Jun; 172(3):455-65. PubMed ID: 23600834
[TBL] [Abstract][Full Text] [Related]
19. NOD2 drives early IL-33-dependent expansion of group 2 innate lymphoid cells during Crohn's disease-like ileitis.
De Salvo C; Buela KA; Creyns B; Corridoni D; Rana N; Wargo HL; Cominelli CL; Delaney PG; Rodriguez-Palacios A; Cominelli F; Vermeire S; Pizarro TT
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33444291
[TBL] [Abstract][Full Text] [Related]
20. CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease.
Papadakis KA; Prehn J; Moreno ST; Cheng L; Kouroumalis EA; Deem R; Breaverman T; Ponath PD; Andrew DP; Green PH; Hodge MR; Binder SW; Targan SR
Gastroenterology; 2001 Aug; 121(2):246-54. PubMed ID: 11487533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
